Bacil Pharma Profit & Loss Annual

Trade
BSE: 524516 | NSE: - | ISIN: INE711D01018 | Sector: Biotechnology & Drugs
45.17 +0.87 (1.96%)Updated : 26 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 0.000.000.000.00
Total Revenue 0.000.000.000.00
Costof Revenue Total 0.000.000.000.00
Gross Profit 0.000.000.000.00
Selling/ General/ Admin Expenses Total 0.100.090.060.05
Depreciation/ Amortization 0.000.000.000.00
Other Operating Expenses Total 0.090.090.100.11
Total Operating Expense 0.190.180.160.17
Operating Income -0.19-0.18-0.16-0.17
Interest Inc( Exp) Net- Non- Op Total 1.280.77-0.06-0.69
Other Net 0.000.000.000.00
Net Income Before Taxes -0.06-0.10-3.86-0.24
Provisionfor Income Taxes 0.000.000.000.00
Net Income After Taxes -0.06-0.10-3.86-0.24
Net Income Before Extra Items -0.06-0.10-3.86-0.24
Net Income -0.06-0.10-3.86-0.24
Income Availableto Com Excl Extra Ord -0.06-0.10-3.86-0.24
Income Availableto Com Incl Extra Ord -0.06-0.10-3.86-0.24
Diluted Net Income -0.06-0.10-3.86-0.24
Diluted Weighted Average Shares 0.590.600.590.58
Diluted EPS Excluding Extra Ord Items -0.10-0.17-6.55-0.41
Diluted Normalized EPS -0.10-0.17-2.47-0.41
Gain( Loss)on Saleof Assets -0.00-36.95-
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,504.70+44.10(1.79%)
1,921.85+32.70(1.73%)
589.05+6.30(1.08%)
11,105.00-351.85 (-3.07%)
HomeMarketsPremiumInstant LoanMint Shorts